Structure–Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers-Reference-Cited by-同舟云学术

Structure–Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers

Published:2016-11-23 Issue:23 Volume:59 Page:10661-10675
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Siegrist Romain¹,Pozzi Davide¹,Jacob Gaël¹,Torrisi Caterina¹,Colas Kilian¹,Braibant Bertrand¹,Mawet Jacques¹,Pfeifer Thomas¹,de Kanter Ruben¹,Roch Catherine¹,Kessler Melanie¹,Corminboeuf Olivier¹,Bezençon Olivier¹^ORCID

Affiliation:

1. Drug Discovery Chemistry, Biology and Pharmacology, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01356

Reference46 articles.

1. Molecular and cellular mechanisms of pharmacoresistance in epilepsy

2. Challenges in the clinical development of new antiepileptic drugs

3. New avenues for anti-epileptic drug discovery and development